Impact of 18F-FDG PET on management in patients with recurrent head and neck cancer: a meta-analysis.

IF 1.3 4区医学 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Nuclear Medicine Communications Pub Date : 2025-06-09 DOI:10.1097/MNM.0000000000002005

Hai-Jeon Yoon, Kyoungjune Pak

{"title":"Impact of 18F-FDG PET on management in patients with recurrent head and neck cancer: a meta-analysis.","authors":"Hai-Jeon Yoon, Kyoungjune Pak","doi":"10.1097/MNM.0000000000002005","DOIUrl":null,"url":null,"abstract":"Objective: Head and neck cancers (HNC) comprise malignancies occurring in the oral cavity, pharynx, larynx, and salivary glands. This meta-analysis assessed the effect of 18F-fluorodeoxyglucose (FDG) PET on the management of recurrent HNC.Methods: We conducted systematic reviews focused on the role of FDG PET in managing recurrent HNC. We defined management change as the percentage of patients whose treatment was altered following FDG PET results relative to those assessed with this imaging technique.Results: We included seven studies encompassing 444 patients. The studies evaluated the role of FDG PET in detecting recurrence or metastasis in HNC patients by examining the rates of management change, with a pooled effect of 26.6%.Conclusion: The findings from our meta-analysis indicate that FDG PET substantially affects the management of patients with recurrent HNC. These outcomes align with current guidelines recommending the use of FDG PET under these circumstances.","PeriodicalId":19708,"journal":{"name":"Nuclear Medicine Communications","volume":" ","pages":""},"PeriodicalIF":1.3000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nuclear Medicine Communications","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/MNM.0000000000002005","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Head and neck cancers (HNC) comprise malignancies occurring in the oral cavity, pharynx, larynx, and salivary glands. This meta-analysis assessed the effect of 18F-fluorodeoxyglucose (FDG) PET on the management of recurrent HNC.

Methods: We conducted systematic reviews focused on the role of FDG PET in managing recurrent HNC. We defined management change as the percentage of patients whose treatment was altered following FDG PET results relative to those assessed with this imaging technique.

Results: We included seven studies encompassing 444 patients. The studies evaluated the role of FDG PET in detecting recurrence or metastasis in HNC patients by examining the rates of management change, with a pooled effect of 26.6%.

Conclusion: The findings from our meta-analysis indicate that FDG PET substantially affects the management of patients with recurrent HNC. These outcomes align with current guidelines recommending the use of FDG PET under these circumstances.

查看原文本刊更多论文

18F-FDG PET对复发性头颈癌患者治疗的影响：荟萃分析

目的：头颈癌（HNC）包括发生在口腔、咽、喉和唾液腺的恶性肿瘤。本荟萃分析评估了18f -氟脱氧葡萄糖（FDG） PET对复发性HNC治疗的影响。方法：我们对FDG PET在治疗复发性HNC中的作用进行了系统回顾。我们将管理改变定义为在FDG PET结果后治疗改变的患者的百分比，相对于使用该成像技术评估的患者。结果：我们纳入了7项研究，共444例患者。这些研究通过检查管理改变率来评估FDG PET在HNC患者中检测复发或转移的作用，总效应为26.6%。结论：我们的荟萃分析结果表明，FDG PET在很大程度上影响了复发性HNC患者的治疗。这些结果与目前建议在这些情况下使用FDG PET的指南一致。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nuclear Medicine Communications 医学-核医学

CiteScore

2.20

自引率

6.70%

发文量

212

审稿时长

3-8 weeks

期刊介绍： Nuclear Medicine Communications, the official journal of the British Nuclear Medicine Society, is a rapid communications journal covering nuclear medicine and molecular imaging with radionuclides, and the basic supporting sciences. As well as clinical research and commentary, manuscripts describing research on preclinical and basic sciences (radiochemistry, radiopharmacy, radiobiology, radiopharmacology, medical physics, computing and engineering, and technical and nursing professions involved in delivering nuclear medicine services) are welcomed, as the journal is intended to be of interest internationally to all members of the many medical and non-medical disciplines involved in nuclear medicine. In addition to papers reporting original studies, frankly written editorials and topical reviews are a regular feature of the journal.